174 related articles for article (PubMed ID: 2182721)
1. Cutaneous IgA deposits in bullous diseases function as ligands to mediate adherence of activated neutrophils.
Hendrix JD; Mangum KL; Zone JJ; Gammon WR
J Invest Dermatol; 1990 May; 94(5):667-72. PubMed ID: 2182721
[TBL] [Abstract][Full Text] [Related]
2. A child with antibodies targeting both linear IgA bullous dermatosis and bullous pemphigoid antigens.
Darling TN; Cardenas AA; Beard JS; Sau P; Yee CL; Zone JJ; Yancey KB
Arch Dermatol; 1995 Dec; 131(12):1438-42. PubMed ID: 7492135
[TBL] [Abstract][Full Text] [Related]
3. A Case of Possible Concurrence of Dermatitis Herpetiformis and Linear Immunoglobulin A / Immunoglobulin G Bullous Dermatosis.
Minakawa S; Matsuzaki Y; Hashimoto T; Ishii N; Nishie W; Sawamura D
Acta Dermatovenerol Croat; 2021 Jul; 29(2):116-117. PubMed ID: 34477081
[TBL] [Abstract][Full Text] [Related]
4. Linear IgA bullous dermatosis. Characterization of a subset of patients with concurrent IgA and IgG anti-basement membrane autoantibodies.
Chan LS; Traczyk T; Taylor TB; Eramo LR; Woodley DT; Zone JJ
Arch Dermatol; 1995 Dec; 131(12):1432-7. PubMed ID: 7492134
[TBL] [Abstract][Full Text] [Related]
5. Histology of linear IgA disease, dermatitis herpetiformis, and bullous pemphigoid.
Blenkinsopp WK; Haffenden GP; Fry L; Leonard JN
Am J Dermatopathol; 1983 Dec; 5(6):547-54. PubMed ID: 6364874
[TBL] [Abstract][Full Text] [Related]
6. Electron microscopic studies in dermatitis herpetiformis in relation to the pattern of immune deposits in the skin.
Dabrowski J; Jablońska S; Chorzelski TP; Jarzabek-Chorzelska M; Maciejewski W
Arch Dermatol Res (1975); 1977 Sep; 259(3):213-24. PubMed ID: 334088
[TBL] [Abstract][Full Text] [Related]
7. Immunofluorescence testing in the diagnosis of autoimmune blistering diseases: overview of 10-year experience.
Arbache ST; Nogueira TG; Delgado L; Miyamoto D; Aoki V
An Bras Dermatol; 2014; 89(6):885-9. PubMed ID: 25387492
[TBL] [Abstract][Full Text] [Related]
8. A subepidermal blistering dermatosis associated with coexistent IgG and IgA anti-dermal basement membrane zone antibodies; demonstration of IgG antibodies reactive against a 200-kDa dermal antigen.
Watanabe M; Tsunoda T; Tagami H
Eur J Dermatol; 2002; 12(6):603-6. PubMed ID: 12459541
[TBL] [Abstract][Full Text] [Related]
9. Linear IgA bullous dermatosis v dermatitis herpetiformis. Quantitative measurements of dermoepidermal alterations.
Smith SB; Harrist TJ; Murphy GF; Halperin AJ; Newell JB; Fallon JT; Fine JD; Mihm MC
Arch Dermatol; 1984 Mar; 120(3):324-8. PubMed ID: 6367664
[TBL] [Abstract][Full Text] [Related]
10. Vesicular pemphigoid vs dermatitis herpetiformis.
Jawitz J; Kumar V; Nigra TP; Beutner EH
J Am Acad Dermatol; 1984 May; 10(5 Pt 2):892-6. PubMed ID: 6373860
[TBL] [Abstract][Full Text] [Related]
11. The ultrastructural localization of IgA deposits in chronic bullous disease of childhood (CBDC).
Dabrowski J; Chorzelski TP; Jablońska S; Kraińska T; Jarzabek-Chorzelska M
J Invest Dermatol; 1979 Jun; 72(6):291-5. PubMed ID: 376753
[TBL] [Abstract][Full Text] [Related]
12. Chronic bullous disease of childhood and linear IgA disease of adults are IgA1-mediated diseases.
Wojnarowska F; Bhogal BS; Black MM
Br J Dermatol; 1994 Aug; 131(2):201-4. PubMed ID: 7917982
[TBL] [Abstract][Full Text] [Related]
13. A subepidermal blistering disease with histopathological features of dermatitis herpetiformis and immunofluorescence characteristics of bullous pemphigoid: a novel subepidermal blistering disease or a variant of bullous pemphigoid?
Salmhofer W; Kawahara Y; Soyer HP; Kerl H; Nishikawa T; Hashimoto T
Br J Dermatol; 1997 Oct; 137(4):599-604. PubMed ID: 9390339
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of neutrophil adherence to antibody by dapsone: a possible therapeutic mechanism of dapsone in the treatment of IgA dermatoses.
Thuong-Nguyen V; Kadunce DP; Hendrix JD; Gammon WR; Zone JJ
J Invest Dermatol; 1993 Apr; 100(4):349-55. PubMed ID: 8454897
[TBL] [Abstract][Full Text] [Related]
15. The role of lymphocytes, granulocytes, mast cells and their related cytokines in lesional skin of linear IgA bullous dermatosis.
Caproni M; Rolfo S; Bernacchi E; Bianchi B; Brazzini B; Fabbri P
Br J Dermatol; 1999 Jun; 140(6):1072-8. PubMed ID: 10354073
[TBL] [Abstract][Full Text] [Related]
16. [Scarring linear IgA dermatosis in the adult].
Kurz K; Mahrle G
Z Hautkr; 1986 Oct; 61(20):1447-55. PubMed ID: 3541412
[TBL] [Abstract][Full Text] [Related]
17. IgA anti-p200 pemphigoid.
Wozniak K; Hashimoto T; Fukuda S; Ohyama B; Ishii N; Koga H; Dainichi T; Kowalewski C
Arch Dermatol; 2011 Nov; 147(11):1306-10. PubMed ID: 22106117
[TBL] [Abstract][Full Text] [Related]
18. The ultrastructural localization of IgA in skin of a patient with mixed form of dermatitis herpetiformis and bullous pemphigoid.
Dabrowski J; Chorzelski TP; Jabłońska S; Kraińska T; Jarzabek-Chorzelska M
J Invest Dermatol; 1978 Feb; 70(2):76-9. PubMed ID: 340593
[TBL] [Abstract][Full Text] [Related]
19. IgA linear dermatosis of childhood (chronic bullous disease of childhood).
Chorzelski TP; Jablonska S
Br J Dermatol; 1979 Nov; 101(5):535-42. PubMed ID: 391262
[TBL] [Abstract][Full Text] [Related]
20. IgA dermatosis in an adult Chinese population. A 10-year study of linear IgA and dermatitis herpetiformis in Singapore.
Ratnam KV
Int J Dermatol; 1988; 27(1):21-4. PubMed ID: 3278990
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
